Balance Sheet Prime Medicine, Inc.

Equities

PRME

US74168J1016

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 06:00:00 18/04/26 am AEST			5-day change	1st Jan Change
3.810 ^USD	+3.81%		+11.08%	+9.80%

17/04	Prime Medicine, Inc. Appoints Svetlana Makhni as Chief Financial Officer	CI
16/04	Prime Medicine Names Svetlana Makhni CFO	MT

ca698e5.RuWMEoP62gCtcznXyL3n7TLv4p-dTRhI2xrvKnuo39c.E6DkdMe7j3X9Qgu4udXQ3me_i9bJKXQPsy-faCvxr7Ysr_xG5ZaDd504bA

Published financial data: PRIME MEDICINE, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	-	-	-	2.98M	4.63M
Total Revenues	-	-	-	2.98M	4.63M
Cost of Goods Sold, Total	70.55M	86.72M	148M	155M	161M
Gross Profit	-70.55M	-86.72M	-148M	-152M	-156M
Selling General & Admin Expenses, Total	13.92M	29.82M	43.39M	50.16M	52.35M
Other Operating Expenses, Total	13.92M	29.82M	43.39M	50.16M	52.35M
Operating Income	-84.47M	-117M	-191M	-202M	-208M
Interest And Investment Income	-	-	-	3.52M	4.15M
Net Interest Expenses	-	-	-	3.52M	4.15M
Other Non Operating Income (Expenses)	-80.99M	1.9M	8.76M	41K	148K
EBT, Excl. Unusual Items	-165M	-115M	-183M	-199M	-204M
Gain (Loss) On Sale Of Investments	-391K	-8.13M	-2.38M	3.02M	2.91M
Other Unusual Items	-	-	-13.5M	-	-
EBT, Incl. Unusual Items	-166M	-123M	-198M	-196M	-201M
Income Tax Expense	-486K	-948K	-279K	-	-
Earnings From Continuing Operations	-165M	-122M	-198M	-196M	-201M
Net Income to Company	-165M	-122M	-198M	-196M	-201M
Net Income - (IS)	-165M	-122M	-198M	-196M	-201M
Preferred Dividend and Other Adjustments	18.75M	20.19M	-	-	-
Net Income to Common Incl Extra Items	-184M	-142M	-198M	-196M	-201M
Net Income to Common Excl. Extra Items	-184M	-142M	-198M	-196M	-201M
Per Share Items
Net EPS - Basic	-14.19	-4.19	-2.18	-1.65	-1.35
Basic EPS - Continuing Operations	-14.19	-4.19	-2.18	-1.65	-1.35
Basic Weighted Average Shares Outstanding	12.97M	33.89M	90.97M	119M	149M
Net EPS - Diluted	-14.19	-4.19	-2.18	-1.65	-1.35
Diluted EPS - Continuing Operations	-14.19	-4.19	-2.18	-1.65	-1.35
Diluted Weighted Average Shares Outstanding	12.97M	33.89M	90.97M	119M	149M
Normalized Basic EPS	-7.97	-2.11	-1.25	-1.05	-0.86
Normalized Diluted EPS	-7.97	-2.11	-1.25	-1.05	-0.86
Supplemental Items
EBITDA	-83.91M	-114M	-187M	-196M	-201M
EBITA	-84.47M	-117M	-191M	-202M	-208M
EBIT	-84.47M	-117M	-191M	-202M	-208M
EBITDAR	-78.8M	-101M	-168M	-172M	-167M
Total Revenues (As Reported)	-	-	-	2.98M	4.63M
Effective Tax Rate - (Ratio)	0.29	0.77	0.14	-	-
Current Domestic Taxes	138K	16K	-	-	-
Total Current Taxes	138K	16K	-	-	-
Deferred Domestic Taxes	-624K	-964K	-279K	-	-
Total Deferred Taxes	-624K	-964K	-279K	-	-
Normalized Net Income	-103M	-71.65M	-114M	-124M	-128M
Supplemental Operating Expense Items
General and Administrative Expenses	13.92M	29.82M	43.39M	50.16M	52.35M
Research And Development Expense From Footnotes	70.55M	86.72M	148M	155M	161M
Net Rental Expense, Total	5.11M	13.51M	18.46M	24.24M	34M
Stock-Based Comp., COGS (Total)	-	4.44M	7.95M	12.7M	19.37M
Stock-Based Comp., G&A Exp. (Total)	-	2.02M	5.96M	13.36M	9.9M
Total Stock-Based Compensation	-	6.46M	13.91M	26.07M	29.27M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	185M	188M	41.57M	182M	63.03M
Short Term Investments	84.2M	106M	80.09M	7.97M	115M
Total Cash And Short Term Investments	270M	294M	122M	190M	178M
Prepaid Expenses	959K	2.7M	19.06M	6.78M	2.94M
Other Current Assets, Total	-	-	2.25M	14.67M	674K
Total Current Assets	271M	297M	143M	212M	181M
Gross Property Plant And Equipment	16.29M	51.38M	44.08M	85.16M	167M
Accumulated Depreciation	-611K	-2.83M	-7.48M	-13.6M	-20.43M
Net Property Plant And Equipment	15.68M	48.55M	36.6M	71.56M	147M
Other Long-Term Assets, Total	15.6M	15.14M	14.28M	14.06M	14.69M
Total Assets	302M	360M	194M	298M	343M
Liabilities
Accounts Payable, Total	1.44M	4.33M	19.54M	11.35M	8.89M
Accrued Expenses, Total	36.19M	8.69M	10.54M	11.82M	10.9M
Current Portion of Leases	7.34M	11.69M	9.28M	3.61M	8.14M
Unearned Revenue Current, Total	-	-	-	7.09M	7.82M
Other Current Liabilities	13.02M	2M	17.07M	4.08M	1.7M
Total Current Liabilities	57.98M	26.71M	56.42M	37.96M	37.45M
Long-Term Leases	3.07M	17.05M	4.36M	37.18M	108M
Unearned Revenue Non Current	-	-	-	63.22M	58.13M
Deferred Tax Liability Non Current	1.24M	279K	-	-	-
Other Non Current Liabilities	-	-	-	6M	18M
Total Liabilities	62.3M	44.04M	60.78M	144M	222M
Preferred Stock Convertible	396M	-	-	-	-
Total Preferred Equity	396M	-	-	-	-
Common Stock, Total	-	2K	2K	2K	2K
Additional Paid In Capital	15.16M	610M	624M	840M	1.01B
Retained Earnings	-171M	-293M	-491M	-687M	-888M
Comprehensive Income and Other	-27K	-384K	-15K	1K	82K
Total Common Equity	-156M	316M	133M	153M	121M
Total Equity	240M	316M	133M	153M	121M
Total Liabilities And Equity	302M	360M	194M	298M	343M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	17.06M	88.4M	115M	128M	177M
ECS Total Common Shares Outstanding	17.06M	88.36M	92.64M	128M	177M
Book Value / Share	-9.16	3.58	1.44	1.2	0.68
Tangible Book Value	-156M	316M	133M	153M	121M
Tangible Book Value Per Share	-9.16	3.58	1.44	1.2	0.68
Total Debt	10.41M	28.74M	13.63M	40.79M	116M
Net Debt	-259M	-265M	-108M	-150M	-61.25M
Debt Equivalent Oper. Leases	40.89M	108M	148M	194M	272M
Account Code - Inventory Valuation	3	-	3	3	3
Machinery, Total	5.42M	19.67M	24.16M	29.29M	32.73M
Full Time Employees	-	175	234	214	146

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-165M	-122M	-198M	-196M	-201M
Depreciation & Amortization - CF	568K	2.22M	4.65M	6.13M	7.32M
Depreciation & Amortization, Total	568K	2.22M	4.65M	6.13M	7.32M
(Gain) Loss From Sale Of Asset	-	8K	28K	-	-
(Gain) Loss on Sale of Investments - (CF)	1.11M	7.88M	-1.03M	-2.61M	-2.37M
Asset Writedown & Restructuring Costs	12.02M	-	-	-	-
Stock-Based Compensation (CF)	1.75M	6.46M	13.91M	26.07M	29.27M
Other Operating Activities, Total	84.67M	8.83M	12.51M	12.36M	9.7M
Change In Accounts Payable	1.18M	2.46M	9.14M	-5.26M	996K
Change in Unearned Revenues	-	-	-	70.31M	-4.36M
Change in Other Net Operating Assets	29.99M	-37.86M	-6.49M	-33.98M	-1.98M
Cash from Operations	-34.08M	-132M	-165M	-123M	-163M
Capital Expenditure	-4.15M	-16.1M	-8.72M	-7.29M	-4.53M
Investment in Marketable and Equity Securities, Total	-68.98M	-30.34M	27.6M	74.75M	-104M
Other Investing Activities, Total	-496K	-665K	-170K	1M	-
Cash from Investing	-73.63M	-47.1M	18.71M	68.46M	-109M
Issuance of Common Stock	-	186M	655K	171M	140M
Issuance of Preferred Stock	270M	-	-	-	-
Other Financing Activities, Total	-1.09M	-4.04M	-	24.8M	12M
Cash from Financing	269M	181M	655K	196M	152M
Net Change in Cash	162M	2.57M	-146M	141M	-120M
Supplemental Items
Levered Free Cash Flow	-8.54M	-118M	-96.21M	-115M	-85.37M
Unlevered Free Cash Flow	-8.54M	-118M	-96.21M	-115M	-85.37M
Change In Net Working Capital	-47.84M	37.36M	-13.51M	12.93M	-12.8M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-29.61	-22	-43.15	-51.51	-40.68
Return on Total Capital	-35.09	-24.48	-48.63	-74.3	-60.39
Return On Equity %	-121.13	-43.83	-88.19	-136.88	-146.81
Return on Common Equity	239.27	-177.48	-88.19	-136.88	-146.81
Margin Analysis
Gross Profit Margin %	-	-	-	-5.11K	-3.37K
SG&A Margin	-	-	-	1.68K	1.13K
EBITDA Margin %	-	-	-	-6.58K	-4.34K
EBITA Margin %	-	-	-	-6.79K	-4.5K
EBIT Margin %	-	-	-	-6.79K	-4.5K
Income From Continuing Operations Margin %	-	-	-	-6.57K	-4.34K
Net Income Margin %	-	-	-	-6.57K	-4.34K
Net Avail. For Common Margin %	-	-	-	-6.57K	-4.34K
Normalized Net Income Margin	-	-	-	-4.17K	-2.75K
Levered Free Cash Flow Margin	-	-	-	-3.84K	-1.84K
Unlevered Free Cash Flow Margin	-	-	-	-3.84K	-1.84K
Asset Turnover
Asset Turnover	-	-	-	0.01	0.01
Fixed Assets Turnover	-	-	-	0.06	0.04
Short Term Liquidity
Current Ratio	4.67	11.1	2.53	5.58	4.84
Quick Ratio	4.65	11	2.16	5.02	4.74
Operating Cash Flow to Current Liabilities	-0.59	-4.93	-2.93	-3.24	-4.34
Average Days Payable Outstanding	4.36	12.14	29.45	36.4	22.99
Long Term Solvency
Total Debt/Equity	4.34	9.09	10.24	26.64	96.33
Total Debt / Total Capital	4.16	8.33	9.29	21.03	49.06
LT Debt/Equity	1.28	5.39	3.27	24.28	89.59
Long-Term Debt / Total Capital	1.23	4.94	2.97	19.17	45.64
Total Liabilities / Total Assets	20.64	12.22	31.35	48.52	64.73
Total Debt / EBITDA	-0.13	-0.29	-0.08	-0.24	-0.7
Net Debt / EBITDA	3.29	2.63	0.64	0.87	0.37
Total Debt / (EBITDA - Capex)	-0.13	-0.25	-0.08	-0.23	-0.68
Net Debt / (EBITDA - Capex)	3.13	2.27	0.61	0.83	0.36
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	-	-	-	55.28
Gross Profit, 1 Yr. Growth %	-3.26K	22.93	70.54	2.98	2.43
EBITDA, 1 Yr. Growth %	9.34K	36.25	63.26	5.2	2.39
EBITA, 1 Yr. Growth %	8.96K	37.96	64.14	5.84	2.91
EBIT, 1 Yr. Growth %	8.96K	37.96	64.14	5.84	2.91
Earnings From Cont. Operations, 1 Yr. Growth %	4.75K	-26.33	62.64	-1.14	2.69
Net Income, 1 Yr. Growth %	4.75K	-26.33	62.64	-1.14	2.69
Normalized Net Income, 1 Yr. Growth %	1.23K	-30.71	59.22	5.68	2.59
Diluted EPS Before Extra, 1 Yr. Growth %	641.1	-70.47	-48.02	-24.17	-18.13
Net Property, Plant and Equip., 1 Yr. Growth %	2.53K	209.7	-24.62	95.52	105.07
Total Assets, 1 Yr. Growth %	451	19.37	-46.2	53.47	15.2
Tangible Book Value, 1 Yr. Growth %	-6.78K	-302.43	-57.92	15.09	-21.08
Common Equity, 1 Yr. Growth %	-6.78K	-302.43	-57.92	15.09	-21.08
Cash From Operations, 1 Yr. Growth %	514.75	286.79	25.48	-25.72	32.31
Capital Expenditures, 1 Yr. Growth %	549.45	287.83	-45.8	-16.39	-37.88
Levered Free Cash Flow, 1 Yr. Growth %	29.77	1.63K	-18.2	19.09	-25.49
Unlevered Free Cash Flow, 1 Yr. Growth %	29.77	1.63K	-18.2	19.09	-25.49
Compound Annual Growth Rate Over Two Years
Gross Profit, 2 Yr. CAGR %	405.58	523.62	44.79	32.52	2.7
EBITDA, 2 Yr. CAGR %	-	1.03K	49.14	31.05	3.78
EBITA, 2 Yr. CAGR %	260.06	1.02K	50.48	31.81	4.36
EBIT, 2 Yr. CAGR %	260.06	1.02K	50.48	31.81	4.36
Earnings From Cont. Operations, 2 Yr. CAGR %	366.86	497.7	9.46	26.8	0.76
Net Income, 2 Yr. CAGR %	366.86	497.7	9.46	26.8	0.76
Normalized Net Income, 2 Yr. CAGR %	367.37	203.94	5.03	31.72	4.12
Diluted EPS Before Extra, 2 Yr. CAGR %	58.67	47.92	-60.82	-37.22	-21.21
Net Property, Plant and Equip., 2 Yr. CAGR %	-	802.59	52.79	21.4	100.24
Total Assets, 2 Yr. CAGR %	489.14	156.46	-19.86	-9.13	32.97
Tangible Book Value, 2 Yr. CAGR %	675.49	1.06K	-7.71	-30.41	-4.7
Common Equity, 2 Yr. CAGR %	675.49	1.06K	-7.71	-30.41	-4.7
Cash From Operations, 2 Yr. CAGR %	191.83	387.63	120.3	-3.46	-0.86
Capital Expenditures, 2 Yr. CAGR %	-	401.87	44.99	-32.68	-27.93
Levered Free Cash Flow, 2 Yr. CAGR %	-	335.81	276.21	-1.3	-5.8
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	335.81	276.21	-1.3	-5.8
Compound Annual Growth Rate Over Three Years
Gross Profit, 3 Yr. CAGR %	-	215.56	304.79	29.24	21.62
EBITDA, 3 Yr. CAGR %	-	-	494.34	32.76	20.7
EBITA, 3 Yr. CAGR %	-	161.52	489.88	33.83	21.37
EBIT, 3 Yr. CAGR %	-	161.52	489.88	33.83	21.37
Earnings From Cont. Operations, 3 Yr. CAGR %	-	152.28	287.32	5.81	18.19
Net Income, 3 Yr. CAGR %	-	152.28	287.32	5.81	18.19
Normalized Net Income, 3 Yr. CAGR %	-	147.35	145.01	6.33	21.19
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-9.41	4.38	-51.18	-31.41
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	294.53	65.88	44.58
Total Assets, 3 Yr. CAGR %	-	246.02	52.38	-0.48	-1.65
Tangible Book Value, 3 Yr. CAGR %	-	395.61	284.66	-0.66	-27.43
Common Equity, 3 Yr. CAGR %	-	395.61	284.66	-0.66	-27.43
Cash From Operations, 3 Yr. CAGR %	-	220.56	210.16	53.33	7.24
Capital Expenditures, 3 Yr. CAGR %	-	-	139	20.68	-34.46
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	149.52	156.4	-10.13
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	149.52	156.4	-10.13
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	-	-2.32
Gross Profit, 5 Yr. CAGR %	-	-	-	123.03	133.87
EBITDA, 5 Yr. CAGR %	-	-	-	-	195.71
EBITA, 5 Yr. CAGR %	-	-	-	98.83	195.04
EBIT, 5 Yr. CAGR %	-	-	-	98.83	195.04
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	91.6	126.02
Net Income, 5 Yr. CAGR %	-	-	-	91.6	126.02
Normalized Net Income, 5 Yr. CAGR %	-	-	-	92.24	75.06
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-21.77	-6.72
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	-	200.79
Total Assets, 5 Yr. CAGR %	-	-	-	102.69	44.3
Tangible Book Value, 5 Yr. CAGR %	-	-	-	125.99	120.14
Common Equity, 5 Yr. CAGR %	-	-	-	125.99	120.14
Cash From Operations, 5 Yr. CAGR %	-	-	-	98.35	96.54
Capital Expenditures, 5 Yr. CAGR %	-	-	-	-	47.96
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	69
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	69